ProCE Banner Series

Targeted Therapy TALK: Translating the Latest Advances Into Precision Care for ALK-Positive Advanced NSCLC

Join us for this interactive, live CME/CE-certified webinar featuring expert perspectives on the use of targeted therapy for advanced ALK-positive NSCLC, with a focus on recent practice-changing studies. Be sure to bring your questions for the live Q&A session with the expert panel.

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This activity is intended for oncologists, oncology nurses and nurse practitioners, physician associates, pharmacists, and other healthcare professionals who care for patients with advanced ALK+ NSCLC.

All Events

Targeted Therapy TALK: Translating the Latest Advances Into Precision Care for ALK-Positive Advanced NSCLC

Upcoming Events

May

07

2025

6:00 PM - 7:00 PM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners' understanding, knowledge, and competence in optimizing the diagnosis, treatment, and management of patients with advanced ALK+ NSCLC. 

Target Audience
This activity is intended for oncologists, oncology nurses and nurse practitioners, physician associates, pharmacists, and other healthcare professionals who care for patients with advanced ALK+ NSCLC.

Learning Objectives
Upon completion of this event, participants should be able to:

  • Increase awareness of the latest clinical data updates relevant to treating patients with advanced ALK+ NSCLC.
  • Describe the clinical relevance of ALK genetic testing for patients and its impact on treatment decision-making.
  • Develop individualized treatment protocols for patients with advanced ALK+ NSCLC based on the latest clinical data, guidelines, and expert insights.
  • Monitor and manage ALK-inhibitor-based treatment adverse events via dose modification and multidisciplinary coordination.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-25-098-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Pfizer Inc.